ABSTRACT
Acute focal cerebral ischemia is a common entity which has been intensively studied both experimentally and clinically. With the accumulation of knowledge, a framework for reducing tissue injury and improving neurological outcome has evolved. It has been clearly established that treatment must be initiated before irreversible damage occurs. The two basic, interdependent approaches are (/) to improve blood flow to the ischemic zone and (2) to increase the resistance of cérébral tissue to métabolic injury. Optimization of blood viscosity and maintenance of systemic arterial blood pressure are important factors in enhancing circulation. Agents such as mahnitol and low-molecular-weight dextran have proved beneficial, whereas prostacyclin and calcium-entry blockers have not. Elevation of blood glucose levels before the ischemic èvent has been shown to have a deleterious effect upon circulatiop and metabolism in the ischemic zone. Barbiturate coma, although difficult to use in the usual clinical setting, has been shown to reduce ischemic injury. The rationale and application of the various therapeutic approaches are discussed.
- Received November 1986.
- Accepted January 1987.
- Copyright © 1987 The Cleveland Clinic Foundation. All Rights Reserved.